Bruker Appoints Philip Ma to its Board of Directors

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005639/en/ Dr. Philip Ma is Chief Executive Officer, President, and Founder of PrognomiQ (Photo: Business... Read more

GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data

Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used by 87 percent of... Read more

Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution

New CellScape™ System Provides Exceptional Quantitative Performance for High-Plex and High-Throughput Targeted Spatial Proteomics ST. LOUIS–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue... Read more

European Society of Radiology and GE Healthcare renew their strategic partnership for ECR 2022

Vienna, Austria – February 21, 2022 – The European Society of Radiology (ESR) and GE Healthcare announce today the renewal of their partnership for the online European Congress of Radiology (ECR Overture) on March 2-6, 2022, and onsite ECR 2022 on July 13-17 in Vienna, Austria. The partnership includes a complete 2,000m² new area and... Read more

Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform

Sierra Surface Plasmon Resonance (SPR) Pro Series for High-Throughput Screening (HTS) Innovative Sierra SPR-32 Pro allowing multiplex HTS for insights into kinetics with no compromise in sensitivity and nature of samples SPR insights into molecular interactions by label-free HTS in support of drug discovery BOSTON–(BUSINESS WIRE)– At the SLAS2022 International Conference and Exhibition, Bruker Corporation... Read more

Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)

Interim data submitted to the FDA show majority of pre-symptomatic babies treated with Evrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies, as well as maintain swallowing Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated... Read more

GE Healthcare, Circle Health Group enter 10-year partnership deal to empower UK clinicians through technology and data

GE Healthcare enters into a comprehensive 10-year partnership with Circle Health Group, covering Circle’s national network of hospitals in the UK Partnership to empower Circle’s clinicians through cutting-edge technology and more impactful use of data Will help ensure better outcomes for NHS patients as well as Circle’s private patients London, UK – January 20 2022... Read more